Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Altimmune, Inc. Common Stock

ALT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ALT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
ALT Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ALT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ALT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ALT holdings by institutional investors

Quarterly net insider trading by ALT's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $80,000 Jul 20, 2021 Issue: Health Issues
  • $50,000 Jul 20, 2021 Issue: Manufacturing Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $80,000 Apr 20, 2021 Issue: Health Issues
  • $40,000 Apr 20, 2021 Issue: Manufacturing Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $90,000 Jan 21, 2021 Issue: Health Issues
  • $50,000 Jan 20, 2021 Issue: Medical/Disease Research/Clinical Labs Manufacturing Health Issues Budget/Appropriations
  • $80,000 Oct 20, 2020 Issue: Health Issues
  • $40,000 Oct 20, 2020 Issue: Budget/Appropriations Manufacturing Health Issues Medical/Disease Research/Clinical Labs
  • $5,000 Jul 20, 2020 Issue: Health Issues
  • $20,000 Jul 20, 2020 Issue: Manufacturing Health Issues Budget/Appropriations Medical/Disease Research/Clinical Labs
  • $30,000 Apr 20, 2020 Issue: Health Issues

Former government officials who have lobbied for ALT

8 former government officials from 4 congressional offices at 3 lobbying firms have lobbied for ALT, most recently Jul 20, 2021.

  • Edward Rogers Other See prior filing Formerly See prior filing · BGR GOVERNMENT AFFAIRS · Jul 20, 2021
  • Brent Del Monte Other See prior filing Formerly See prior filing · BGR GOVERNMENT AFFAIRS · Jul 20, 2021
  • John Stone Other See prior filing Formerly See prior filing · BGR GOVERNMENT AFFAIRS · Jul 20, 2021
  • Remy Mason Other See prior filing Formerly See prior filing · BGR GOVERNMENT AFFAIRS · Jul 20, 2021
  • Jeff Sessions
    David Stewart Senate Legislative Correspondent, Senator Jeff Sessions Formerly with Jeff Sessions · BRADLEY ARANT BOULT CUMMINGS LLP · Jul 20, 2020
  • George R. Nethercutt Jr.
    Paul Kavinoky House Legislative Director, Representative George Nethercutt; Deputy Chief of Staff, Representative Richard Pombo Formerly with George R. Nethercutt Jr. · BRADLEY ARANT BOULT CUMMINGS LLP · Jul 20, 2020
  • Chad Schulken Congress Clerk/Staff Director/Professional Staff, Military Construction, Veterans Affairs, and Related Agencies Subcommittee, Committee on Appropriations; Professional Staff, Commerce, Justice, State & Judiciary Subcommittee, Committee on Appropriations Formerly Clerk/Staff Director/Professional Staff, Military Construction, Veterans Affairs · VAN SCOYOC ASSOCIATES · Jul 20, 2020
  • Jeff Sessions
    Graham Hall Senate New Intern, Senator Jeff Sessions; Intern, Congressman Robert Aderholt Formerly with Jeff Sessions · VAN SCOYOC ASSOCIATES · Jun 24, 2020

ALT Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ALT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ALT Income Statement
ALT Balance Sheet
ALT Cash Flow
U.S. Patents

New ALT patent grants

  • Patent Title: Peptide pharmaceuticals for treatment of nash and other disorders Jan. 03, 2023
  • Patent Title: Coronavirus immunogenic compositions and uses thereof Jul. 12, 2022
  • Patent Title: Rapid and prolonged immunologic-therapeutic Oct. 12, 2021
  • Patent Title: Rapid and prolonged immunogic therapeutic Jun. 22, 2021
  • Patent Title: Rapid and prolonged immunologic therapeutic Jun. 22, 2021
  • Patent Title: Immunization of avians by administration of non-replicating vectored vaccines Aug. 18, 2020
  • Patent Title: Rapid and prolonged immunologic-therapeutic Jan. 22, 2019
  • Patent Title: Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax May. 15, 2018
  • Patent Title: Rapid and prolonged immunologic-therapeutic Mar. 28, 2017
  • Patent Title: Rapid and prolonged immunologic-therapeutic Nov. 03, 2015
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ALT from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ALT News

Recent insights relating to ALT

CNBC Recommendations

Recent picks made for ALT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ALT

ALT Analyst Ratings

ALT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ALT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ALT stock a Buy, Sell, or Hold?

  • What is the price target for $ALT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ALT Top Shareholders
Shareholder
Shares Held
ALT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ALT stock?

  • Who owns the most shares of $ALT stock?

  • What funds own $ALT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ALT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ALT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ALT

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

  • Address Gaithersburg, MD
  • Market Cap 620.5 million
  • Employees 57
  • Industrial Classification Pharmaceutical Preparations

Altimmune, Inc. Common Stock (ALT) Historical Stock Prices

Altimmune, Inc. Common Stock (ALT) closed at $3.19 on September 23, 2026. Over the past year its adjusted close ranged from $2.59 to $6.18. Daily prices go back to May 5, 2017, 2,359 trading days in all.

  • 1 month+2.57%
  • 3 months+8.14%
  • Year to date-11.63%
  • 1 year-15.83%
  • 3 years+22.22%
  • 5 years-78.69%
  • Max-59.67%
See every congressional and insider trade on the ALT price chart

Quiver Premium charts ALT's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 3.42 3.42 3.15 3.19 3.19 4,531,546
Sep 22, 2026 3.33 3.41 3.25 3.41 3.41 4,003,284
Sep 21, 2026 3.31 3.34 3.24 3.27 3.27 3,523,049
Sep 18, 2026 3.23 3.26 3.18 3.25 3.25 12,176,850
Sep 17, 2026 3.31 3.35 3.21 3.24 3.24 3,457,393
Sep 16, 2026 3.27 3.29 3.19 3.24 3.24 3,331,820
Sep 15, 2026 3.30 3.31 3.21 3.23 3.23 2,339,114
Sep 14, 2026 3.27 3.36 3.27 3.30 3.30 2,465,554
Sep 11, 2026 3.33 3.41 3.26 3.27 3.27 2,704,721
Sep 10, 2026 3.32 3.35 3.25 3.29 3.29 2,563,020
Sep 9, 2026 3.35 3.42 3.29 3.35 3.35 3,076,359
Sep 8, 2026 3.46 3.55 3.34 3.36 3.36 3,591,744
Sep 4, 2026 3.28 3.43 3.25 3.42 3.42 4,871,948
Sep 3, 2026 3.30 3.32 3.19 3.23 3.23 2,552,090
Sep 2, 2026 3.10 3.34 3.10 3.28 3.28 7,472,170
Sep 1, 2026 3.07 3.10 3.02 3.09 3.09 2,355,221
Aug 31, 2026 3.08 3.13 3.06 3.11 3.11 2,216,476
Aug 28, 2026 3.21 3.23 3.06 3.11 3.11 3,193,611
Aug 27, 2026 3.19 3.25 3.13 3.24 3.24 2,278,580
Aug 26, 2026 3.20 3.20 3.09 3.15 3.15 4,050,554
Aug 25, 2026 3.14 3.23 3.11 3.20 3.20 3,819,791
Aug 24, 2026 3.13 3.13 3.02 3.11 3.11 2,724,598
Aug 21, 2026 2.98 3.24 2.95 3.11 3.11 6,157,414
Aug 20, 2026 3.07 3.08 2.92 2.95 2.95 4,681,380
Aug 19, 2026 3.04 3.20 3.00 3.12 3.12 10,824,068
Aug 18, 2026 2.99 3.03 2.96 2.97 2.97 2,472,114
Aug 17, 2026 2.94 3.02 2.90 3.00 3.00 4,056,884
Aug 14, 2026 2.95 2.97 2.86 2.94 2.94 3,073,969
Aug 13, 2026 2.95 2.96 2.84 2.88 2.88 4,108,985
Aug 12, 2026 3.05 3.20 2.92 2.93 2.93 6,045,805
Aug 11, 2026 3.06 3.08 2.98 3.00 3.00 3,634,639
Aug 10, 2026 3.09 3.10 2.99 3.05 3.05 5,260,453
Aug 7, 2026 3.05 3.10 3.00 3.08 3.08 4,506,100
Aug 6, 2026 3.03 3.05 2.95 3.01 3.01 3,977,253
Aug 5, 2026 3.07 3.12 3.00 3.03 3.03 3,163,967
Aug 4, 2026 3.01 3.08 2.95 3.07 3.07 8,162,984
Aug 3, 2026 2.88 3.02 2.85 3.00 3.00 4,647,347
Jul 31, 2026 2.99 2.99 2.78 2.84 2.84 3,892,079
Jul 30, 2026 2.92 3.00 2.86 2.98 2.98 5,439,362
Jul 29, 2026 3.00 3.10 2.90 2.92 2.92 8,301,360
Jul 28, 2026 3.16 3.31 2.81 2.99 2.99 17,142,614
Jul 27, 2026 2.80 3.03 2.80 2.96 2.96 4,060,013
Jul 24, 2026 2.85 2.89 2.76 2.77 2.77 1,911,556
Jul 23, 2026 2.79 2.84 2.75 2.84 2.84 1,625,861
Jul 22, 2026 2.81 2.87 2.77 2.81 2.81 2,290,537
Jul 21, 2026 2.81 2.87 2.78 2.82 2.82 1,984,647
Jul 20, 2026 2.89 2.91 2.79 2.81 2.81 2,614,486
Jul 17, 2026 2.79 2.95 2.77 2.87 2.87 2,963,768
Jul 16, 2026 2.96 2.97 2.81 2.85 2.85 2,995,414
Jul 15, 2026 2.94 3.00 2.88 2.98 2.98 2,862,398
Jul 14, 2026 2.98 3.02 2.90 2.93 2.93 3,298,979
Jul 13, 2026 3.01 3.02 2.92 2.99 2.99 2,457,098
Jul 10, 2026 3.12 3.13 2.95 3.05 3.05 2,992,854
Jul 9, 2026 3.11 3.15 3.04 3.12 3.12 2,876,992
Jul 8, 2026 2.94 3.11 2.93 3.11 3.11 3,520,264
Jul 7, 2026 3.08 3.12 2.96 3.02 3.02 4,619,754
Jul 6, 2026 3.25 3.30 3.08 3.08 3.08 4,348,091
Jul 2, 2026 3.18 3.26 3.10 3.16 3.16 4,077,524
Jul 1, 2026 3.02 3.40 3.00 3.15 3.15 7,975,988
Jun 30, 2026 2.95 3.14 2.91 3.04 3.04 4,332,484
Jun 29, 2026 2.85 2.94 2.79 2.94 2.94 3,638,874
Jun 26, 2026 2.85 2.90 2.74 2.82 2.82 17,105,423
Jun 25, 2026 2.96 3.00 2.86 2.87 2.87 2,782,884
Jun 24, 2026 2.92 3.04 2.92 2.95 2.95 3,494,078
Jun 23, 2026 2.88 3.04 2.88 2.91 2.91 4,223,911
Jun 22, 2026 2.84 3.04 2.83 2.93 2.93 5,776,510
Jun 18, 2026 2.68 2.77 2.68 2.70 2.70 11,688,234
Jun 17, 2026 2.65 2.71 2.62 2.64 2.64 3,570,898
Jun 16, 2026 2.64 2.68 2.60 2.62 2.62 2,907,175
Jun 15, 2026 2.62 2.68 2.58 2.64 2.64 3,516,863
Jun 12, 2026 2.61 2.66 2.58 2.61 2.61 2,144,903
Jun 11, 2026 2.62 2.65 2.57 2.59 2.59 3,425,331
Jun 10, 2026 2.62 2.71 2.60 2.61 2.61 3,042,400
Jun 9, 2026 2.77 2.80 2.62 2.66 2.66 3,352,798
Jun 8, 2026 2.75 2.78 2.68 2.73 2.73 2,172,837
Jun 5, 2026 2.92 2.92 2.69 2.71 2.71 3,129,223
Jun 4, 2026 2.84 3.00 2.84 2.92 2.92 2,818,707
Jun 3, 2026 2.93 2.95 2.84 2.87 2.87 3,033,284
Jun 2, 2026 2.99 3.00 2.90 2.90 2.90 3,144,481
Jun 1, 2026 3.02 3.04 2.93 3.01 3.01 2,294,436
May 29, 2026 3.07 3.10 3.02 3.05 3.05 2,596,555
May 28, 2026 2.98 3.13 2.98 3.07 3.07 3,932,808
May 27, 2026 2.99 3.03 2.96 2.98 2.98 2,597,333
May 26, 2026 2.90 3.00 2.89 2.93 2.93 2,154,109
May 22, 2026 2.94 3.00 2.88 2.90 2.90 1,989,306
May 21, 2026 2.80 2.93 2.77 2.93 2.93 3,062,762
May 20, 2026 2.75 2.85 2.73 2.82 2.82 2,229,240
May 19, 2026 2.80 2.84 2.73 2.74 2.74 2,514,293
May 18, 2026 2.85 2.89 2.72 2.80 2.80 3,462,113
May 15, 2026 2.90 2.94 2.81 2.85 2.85 2,286,910
May 14, 2026 3.01 3.03 2.90 2.92 2.92 2,388,445
May 13, 2026 2.98 3.04 2.89 3.02 3.02 3,584,637
May 12, 2026 3.08 3.10 3.00 3.08 3.08 2,436,619
May 11, 2026 3.09 3.22 3.06 3.09 3.09 2,937,164
May 8, 2026 3.07 3.11 3.01 3.09 3.09 2,858,248
May 7, 2026 3.22 3.24 3.00 3.04 3.04 3,720,531
May 6, 2026 3.06 3.26 3.04 3.26 3.26 4,096,720
May 5, 2026 3.08 3.15 3.00 3.06 3.06 3,470,414
May 4, 2026 2.84 3.04 2.84 3.02 3.02 5,175,677
May 1, 2026 2.59 2.82 2.56 2.82 2.82 4,956,786
Apr 30, 2026 2.66 2.67 2.58 2.60 2.60 5,675,474
Apr 29, 2026 2.71 2.73 2.60 2.63 2.63 4,888,585
Apr 28, 2026 2.78 2.85 2.72 2.74 2.74 4,870,640
Apr 27, 2026 2.86 2.90 2.75 2.80 2.80 5,894,919
Apr 24, 2026 2.95 3.01 2.82 2.85 2.85 14,733,746
Apr 23, 2026 3.08 3.16 2.80 2.89 2.89 30,489,038
Apr 22, 2026 3.45 3.51 3.42 3.47 3.47 2,948,086
Apr 21, 2026 3.56 3.64 3.39 3.41 3.41 3,251,026
Apr 20, 2026 3.45 3.58 3.39 3.56 3.56 2,161,883
Apr 17, 2026 3.55 3.60 3.42 3.50 3.50 2,868,797
Apr 16, 2026 3.40 3.55 3.35 3.51 3.51 2,580,475
Apr 15, 2026 3.33 3.42 3.29 3.40 3.40 2,080,063
Apr 14, 2026 3.25 3.32 3.23 3.29 3.29 1,990,993
Apr 13, 2026 3.23 3.28 3.18 3.23 3.23 2,122,551
Apr 10, 2026 3.39 3.41 3.22 3.24 3.24 1,936,610
Apr 9, 2026 3.35 3.44 3.31 3.38 3.38 1,989,237
Apr 8, 2026 3.48 3.54 3.35 3.37 3.37 1,695,749
Apr 7, 2026 3.34 3.45 3.25 3.38 3.38 2,039,568
Apr 6, 2026 3.34 3.48 3.30 3.33 3.33 2,360,635
Apr 2, 2026 3.10 3.35 3.07 3.34 3.34 2,737,035
Apr 1, 2026 3.14 3.23 3.10 3.12 3.12 2,111,656
Mar 31, 2026 2.98 3.12 2.95 3.08 3.08 3,290,532
Mar 30, 2026 3.03 3.03 2.87 2.88 2.88 3,116,331
Mar 27, 2026 3.16 3.19 3.02 3.02 3.02 2,674,890
Mar 26, 2026 3.26 3.33 3.19 3.20 3.20 2,194,819
Mar 25, 2026 3.30 3.38 3.23 3.31 3.31 4,369,468
Mar 24, 2026 3.37 3.41 3.23 3.24 3.24 3,345,417
Mar 23, 2026 3.40 3.53 3.31 3.44 3.44 3,449,313
Mar 20, 2026 3.43 3.52 3.31 3.34 3.34 12,523,672
Mar 19, 2026 3.38 3.51 3.34 3.42 3.42 2,686,763
Mar 18, 2026 3.50 3.52 3.36 3.42 3.42 3,477,122
Mar 17, 2026 3.63 3.71 3.52 3.53 3.53 2,531,622
Mar 16, 2026 3.60 3.68 3.54 3.62 3.62 2,650,194
Mar 13, 2026 3.62 3.68 3.47 3.50 3.50 3,119,120
Mar 12, 2026 3.77 3.77 3.58 3.60 3.60 2,959,387
Mar 11, 2026 3.89 3.91 3.74 3.80 3.80 2,890,344
Mar 10, 2026 3.90 4.04 3.83 3.86 3.86 3,565,682
Mar 9, 2026 3.64 3.89 3.61 3.88 3.88 5,337,005
Mar 6, 2026 3.54 3.75 3.42 3.54 3.54 5,385,353
Mar 5, 2026 4.10 4.20 3.50 3.50 3.50 7,709,994
Mar 4, 2026 4.19 4.35 4.13 4.27 4.27 2,267,348
Mar 3, 2026 4.05 4.26 4.04 4.16 4.16 2,863,833
Mar 2, 2026 4.24 4.27 4.15 4.16 4.16 2,388,473
Feb 27, 2026 4.40 4.47 4.29 4.31 4.31 3,018,485
Feb 26, 2026 4.56 4.59 4.38 4.46 4.46 1,902,855
Feb 25, 2026 4.59 4.61 4.49 4.56 4.56 2,056,523
Feb 24, 2026 4.52 4.83 4.52 4.57 4.57 2,978,948
Feb 23, 2026 4.34 4.64 4.34 4.52 4.52 3,179,227
Feb 20, 2026 4.49 4.51 4.36 4.38 4.38 4,136,634
Feb 19, 2026 4.47 4.53 4.27 4.49 4.49 3,275,381
Feb 18, 2026 4.50 4.55 4.42 4.46 4.46 2,829,078
Feb 17, 2026 4.54 4.64 4.48 4.50 4.50 1,885,381
Feb 13, 2026 4.62 4.75 4.53 4.53 4.53 3,887,968
Feb 12, 2026 4.65 4.70 4.47 4.57 4.57 2,236,562
Feb 11, 2026 4.72 4.75 4.54 4.63 4.63 1,866,963
Feb 10, 2026 4.70 4.83 4.62 4.65 4.65 2,140,747
Feb 9, 2026 4.85 4.96 4.65 4.69 4.69 3,722,751
Feb 6, 2026 5.00 5.08 4.84 4.87 4.87 3,846,002
Feb 5, 2026 5.09 5.28 4.88 4.92 4.92 3,972,566
Feb 4, 2026 5.47 5.53 5.08 5.13 5.13 3,557,492
Feb 3, 2026 5.54 5.64 5.21 5.47 5.47 4,565,876
Feb 2, 2026 5.56 5.75 5.26 5.55 5.55 5,175,809
Jan 30, 2026 5.05 5.66 5.03 5.60 5.60 6,280,832
Jan 29, 2026 5.22 5.49 5.03 5.10 5.10 4,089,514
Jan 28, 2026 5.93 6.36 5.04 5.12 5.12 13,079,967
Jan 27, 2026 5.64 6.22 5.60 6.18 6.18 5,788,732
Jan 26, 2026 5.50 5.69 5.19 5.66 5.66 5,736,699
Jan 23, 2026 5.40 6.44 5.34 5.50 5.50 15,507,157
Jan 22, 2026 4.65 5.40 4.65 5.38 5.38 8,194,956
Jan 21, 2026 4.25 4.62 4.19 4.62 4.62 3,909,231
Jan 20, 2026 4.10 4.26 4.03 4.23 4.23 4,516,644
Jan 16, 2026 4.30 4.37 4.17 4.24 4.24 2,598,239
Jan 15, 2026 4.15 4.40 4.05 4.24 4.24 4,553,954
Jan 14, 2026 4.00 4.21 3.98 4.18 4.18 3,266,539
Jan 13, 2026 4.04 4.09 3.96 4.01 4.01 2,604,176
Jan 12, 2026 4.08 4.12 4.00 4.05 4.05 2,763,838
Jan 9, 2026 4.12 4.18 3.98 4.02 4.02 3,075,210
Jan 8, 2026 4.15 4.22 4.02 4.08 4.08 3,843,084
Jan 7, 2026 4.00 4.36 3.98 4.19 4.19 7,287,334
Jan 6, 2026 4.08 4.18 3.86 3.96 3.96 5,650,592
Jan 5, 2026 4.09 4.53 3.96 4.09 4.09 27,007,058
Jan 2, 2026 3.62 3.66 3.48 3.51 3.51 3,567,389
Dec 31, 2025 3.60 3.62 3.52 3.61 3.61 4,293,108
Dec 30, 2025 3.68 3.72 3.60 3.61 3.61 3,158,386
Dec 29, 2025 3.84 3.84 3.65 3.68 3.68 4,528,500
Dec 26, 2025 3.97 3.99 3.84 3.86 3.86 2,924,280
Dec 24, 2025 4.05 4.11 3.97 3.98 3.98 2,079,886
Dec 23, 2025 4.10 4.16 3.98 4.00 4.00 4,440,938
Dec 22, 2025 3.96 4.45 3.95 4.14 4.14 6,879,449
Dec 19, 2025 4.58 4.59 3.83 3.90 3.90 22,528,357
Dec 18, 2025 5.23 5.28 5.02 5.05 5.05 2,860,175
Dec 17, 2025 5.03 5.37 5.02 5.09 5.09 2,877,214
Dec 16, 2025 5.22 5.28 4.92 5.03 5.03 4,613,766
Dec 15, 2025 5.29 5.50 5.17 5.28 5.28 3,707,900
Dec 12, 2025 5.39 6.03 5.25 5.27 5.27 6,381,933
Dec 11, 2025 5.40 5.63 5.31 5.34 5.34 2,785,805
Dec 10, 2025 5.49 5.56 5.36 5.43 5.43 3,354,527
Dec 9, 2025 5.69 5.83 5.37 5.52 5.52 4,808,229
Dec 8, 2025 5.35 5.74 5.03 5.61 5.61 5,549,220
Dec 5, 2025 5.31 5.44 5.19 5.24 5.24 2,583,807
Dec 4, 2025 5.09 5.46 5.00 5.31 5.31 3,112,724
Dec 3, 2025 4.82 5.15 4.70 5.11 5.11 2,566,364
Dec 2, 2025 5.00 5.00 4.75 4.76 4.76 3,020,974
Dec 1, 2025 5.08 5.12 4.73 4.93 4.93 4,393,552
Nov 28, 2025 5.21 5.33 5.15 5.26 5.26 2,119,835
Nov 26, 2025 5.11 5.31 5.10 5.17 5.17 2,561,290
Nov 25, 2025 5.10 5.25 4.98 5.14 5.14 3,326,056
Nov 24, 2025 4.83 5.19 4.80 5.10 5.10 4,683,627
Nov 21, 2025 4.46 4.88 4.44 4.81 4.81 3,481,434
Nov 20, 2025 4.67 4.71 4.40 4.47 4.47 2,995,081
Nov 19, 2025 4.54 4.75 4.51 4.59 4.59 4,030,761
Nov 18, 2025 4.16 4.73 4.09 4.65 4.65 4,334,226
Nov 17, 2025 4.14 4.22 4.07 4.19 4.19 2,313,741
Nov 14, 2025 3.95 4.22 3.95 4.17 4.17 2,628,365
Nov 13, 2025 4.18 4.22 4.03 4.06 4.06 2,434,039
Nov 12, 2025 4.30 4.35 4.12 4.23 4.23 2,374,134
Nov 11, 2025 4.26 4.31 4.14 4.28 4.28 2,976,975
Nov 10, 2025 4.20 4.36 4.06 4.26 4.26 6,038,077
Nov 7, 2025 3.92 4.16 3.77 4.11 4.11 4,258,000
Nov 6, 2025 3.82 4.12 3.76 3.94 3.94 4,248,643
Nov 5, 2025 3.75 3.83 3.73 3.75 3.75 2,647,526
Nov 4, 2025 3.89 3.98 3.74 3.76 3.76 3,174,992
Nov 3, 2025 4.03 4.05 3.92 3.96 3.96 2,188,903
Oct 31, 2025 4.25 4.25 3.99 4.05 4.05 2,447,365
Oct 30, 2025 4.05 4.25 4.02 4.07 4.07 4,023,729
Oct 29, 2025 4.06 4.07 3.93 4.00 4.00 2,310,206
Oct 28, 2025 4.15 4.15 4.04 4.06 4.06 1,746,263
Oct 27, 2025 3.99 4.15 3.99 4.14 4.14 2,921,859
Oct 24, 2025 4.00 4.10 3.94 3.95 3.95 1,931,864
Oct 23, 2025 3.90 4.04 3.90 3.96 3.96 1,944,748
Oct 22, 2025 4.00 4.00 3.83 3.90 3.90 2,698,766
Oct 21, 2025 3.98 4.10 3.95 4.04 4.04 2,284,578
Oct 20, 2025 3.87 4.06 3.86 4.00 4.00 3,013,303
Oct 17, 2025 3.85 3.94 3.79 3.83 3.83 2,133,720
Oct 16, 2025 4.00 4.15 3.88 3.89 3.89 2,826,394
Oct 15, 2025 3.98 4.11 3.94 4.00 4.00 2,277,059
Oct 14, 2025 3.92 4.00 3.82 3.97 3.97 2,010,525
Oct 13, 2025 3.92 4.04 3.85 4.00 4.00 3,098,514
Oct 10, 2025 4.03 4.11 3.90 3.92 3.92 2,649,549
Oct 9, 2025 4.00 4.05 3.92 4.00 4.00 2,847,848
Oct 8, 2025 3.96 4.18 3.90 3.93 3.93 7,869,370
Oct 7, 2025 4.02 4.03 3.86 3.93 3.93 1,873,742
Oct 6, 2025 3.93 4.05 3.85 4.01 4.01 2,485,400
Oct 3, 2025 3.94 4.06 3.88 3.91 3.91 2,560,050
Oct 2, 2025 3.88 3.95 3.83 3.93 3.93 2,098,438
Oct 1, 2025 3.76 4.05 3.75 3.87 3.87 3,045,250
Sep 30, 2025 3.77 3.80 3.68 3.77 3.77 2,667,118
Sep 29, 2025 4.00 4.02 3.75 3.79 3.79 3,181,032
Sep 26, 2025 3.92 4.00 3.79 4.00 4.00 2,499,805
Sep 25, 2025 3.91 4.14 3.83 3.92 3.92 3,222,453
Sep 24, 2025 3.80 3.96 3.80 3.92 3.92 1,956,082
Sep 23, 2025 3.96 3.97 3.78 3.79 3.79 1,795,203

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Altimmune, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ALT, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation